Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis
- PMID: 20044756
- PMCID: PMC2864729
- DOI: 10.1007/s00401-009-0632-y
Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis
Conflict of interest statement
Figures
References
-
- Balss J, Meyer J, Mueller W, et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008;116:597–602. - PubMed
-
- Bleeker FE, Lamba S, Leenstra S, et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat. 2009;30:7–11. - PubMed
-
- Bruner JM, Saya H, Moser RP. Immunocytochemical detection of p53 in human gliomas. Mod Pathol. 1991;4:671–674. - PubMed
-
- Capper D, Zentgraf H, Balss J, et al. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol. 2009;118:599–601. - PubMed
-
- Hartmann C, Meyer J, Balss J, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligo-dendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol. 2009;118:469–474. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
